- Home
- NVGS vs STAA Comparison
NVGS vs STAA Comparison
Compare NVGS & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVGS
- STAA
- Stock Information
- Founded
- NVGS 1997
- STAA 1982
- Country
- NVGS United Kingdom
- STAA United States
- Employees
- NVGS N/A
- STAA N/A
- Industry
- NVGS Marine Transportation
- STAA Ophthalmic Goods
- Sector
- NVGS Consumer Discretionary
- STAA Health Care
- Exchange
- NVGS Nasdaq
- STAA Nasdaq
- Market Cap
- NVGS 1.1B
- STAA 1.2B
- IPO Year
- NVGS N/A
- STAA N/A
- Fundamental
- Price
- NVGS $16.99
- STAA $23.52
- Analyst Decision
- NVGS Strong Buy
- STAA Buy
- Analyst Count
- NVGS 3
- STAA 7
- Target Price
- NVGS $22.00
- STAA $42.83
- AVG Volume (30 Days)
- NVGS 218.6K
- STAA 701.0K
- Earning Date
- NVGS 03-12-2025
- STAA 02-19-2025
- Dividend Yield
- NVGS 1.18%
- STAA N/A
- EPS Growth
- NVGS 13.48
- STAA 9.97
- EPS
- NVGS 1.12
- STAA 0.44
- Revenue
- NVGS $564,280,000.00
- STAA $341,224,000.00
- Revenue This Year
- NVGS $0.05
- STAA $8.37
- Revenue Next Year
- NVGS $4.76
- STAA $10.55
- P/E Ratio
- NVGS $14.81
- STAA $52.79
- Revenue Growth
- NVGS 5.99
- STAA 10.01
- 52 Week Low
- NVGS $14.55
- STAA $21.13
- 52 Week High
- NVGS $18.18
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- NVGS 61.23
- STAA 44.66
- Support Level
- NVGS $16.14
- STAA $22.49
- Resistance Level
- NVGS $17.23
- STAA $24.50
- Average True Range (ATR)
- NVGS 0.47
- STAA 0.96
- MACD
- NVGS 0.01
- STAA 0.15
- Stochastic Oscillator
- NVGS 69.38
- STAA 50.24
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture).
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.